| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| R&D Expense | $42.3M | +8.7% |
| SG&A Expense | $20.7M | +62.4% |
| Operating Income | -$63.1M | -21.9% |
| Pre-tax Income | -$66.0M | -24.2% |
| Income Tax | $3K | +40.0% |
| Net Income | -$66.1M | -24.2% |
| EPS (Basic) | -$0.31 | +11.4% |
| EPS (Diluted) | -$0.31 | +11.4% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.4M | +20.2% |
| Current Assets | $27.5M | +28.0% |
| Total Assets | $28.5M | +25.1% |
| Current Liabilities | $19.7M | +192.2% |
| Total Liabilities | $19.8M | +8.7% |
| Stockholders' Equity | $8.7M | +89.6% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$56.7M | -4.5% |
| Financing Cash Flow | $59.6M | +6.0% |